MedTrace Logo

Longitudinal Assessment of Exercise Capacity and Vascular Function in Patients With CF

NCT03338595 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-01-19

No results posted yet for this study

Summary

This project is an attempt to understand how Orkambi treatment affects exercise capacity and the function of the arteries in CF patients who are homozygous F508del. Our goal is to perform the exercise and vascular measurements every 3 months after a patient starts taking Orkambi.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Ryan Harris, PhD · Augusta University

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2020-10-31
Completion
2020-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03338595 on ClinicalTrials.gov